InvestorsHub Logo
Followers 8
Posts 119
Boards Moderated 0
Alias Born 11/10/2022

Re: Kydg post# 6192

Thursday, 02/08/2024 12:48:41 PM

Thursday, February 08, 2024 12:48:41 PM

Post# of 7575
$100M in quarterly revenue should get us close to non-gaap operating cash flow breakeven. that is 65% y/y revenue growth.
My Q4 2024 revenue targets:
$40M RHA
$45M Daxi Aesthetic
$15M Daxi Therapeutic

With $400M annual sales run rate and a clear path to $1B sales by 2026 and no need for further financing should allow stock to trade at or above $3B EV by early 2025. This does not factor in a disorderly short squeeze.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News